Smofkabiven Peripheral 130 mg

SMOFKABIVEN Peripheral 130 mg is an intravenous emulsion containing sodium glycerophosphate, designed for nutritional support. This product is manufactured by Fresenius Kabi Canada Ltd. and is suitable for peripheral administration.

SMOFKABIVEN Peripheral 130 mg is primarily used for providing essential nutrients to patients who cannot consume food orally. It is often utilized in clinical settings to support patients requiring intravenous nutrition. This emulsion helps deliver vital nutrients directly into the bloodstream, aiding in overall health maintenance and recovery.

When administered intravenously, SMOFKABIVEN Peripheral 130 mg provides essential nutrients directly into the bloodstream. This can help support overall health and aid in recovery for patients who cannot consume food orally. The emulsion is designed to be well-tolerated, but individual responses may vary.

SMOFKABIVEN Peripheral 130 mg should be administered under medical supervision. It is important to follow proper handling and storage guidelines to maintain the integrity of the emulsion. Patients with certain medical conditions or allergies should consult their healthcare provider before use.

SMOFKABIVEN Peripheral 130 mg may interact with other medications or supplements. It is important to inform your healthcare provider about all medications you are taking. Additionally, interactions with certain medical conditions should be considered before administration.